Skip to content
healthcare.dev

AUSTEDO XR

NDC 68546-475, deutetrabenazine, tablet, film coated, extended release, from Teva Neuroscience, Inc..

Product NDC
68546-475
Status
Listed
Labeler
Teva Neuroscience, Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216354
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68546-475 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEUTETRABENAZINE42 mg/1
Package NDCNDC-11Package
68546-475-566854604755630 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68546-475-56)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7ea3c60a-45c7-44cc-afc2-d87fa53993c0
  • NADAC price for package 68546047556

    GET /v1/drugs/nadac/68546047556

Use it

Look up 68546-475 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68546-475 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68546-475. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.